Figure 1.
Serum lipid change 1 year after switching to TAF/FTC/BIC among subcategories receiving NNRTI-containing regimens at baseline. BIC: Bictegravir sodium; EFV: Efavirenz; FTC: Emtricitabine; HDL: High-density lipoprotein; LDL: Low-density lipoprotein; NNRTI: Non-nucleotide reverse transcriptase inhibitor; NVP: Nevirapine; TAF: Tenofovir alafenamide; TC: Total cholesterol; TG: Triglyceride.